Literature DB >> 19273232

A Web-based platform for interdisciplinary biomedical research.

Guenter Schreier1, Juergen Messmer, Guenter Rauchegger, Robert Modre-Osprian, Ruth Ladenstein.   

Abstract

The European Neuroblastoma Group of the International Society for Paediatric Oncology (SIOPEN) is dedicated to the research and treatment of neuroblastoma. The medical research network SIOPEN-R-NET is an extensive web-based European IT network for interdisciplinary biomedical research. The IT infrastructure has been built using state-of-the-art multi-tiered architecture principles. Basic features required for electronic data capture in clinical trials were implemented. Additionally, advanced tools were developed for registration, review, user management, communication and image management. Currently three clinical trials and eight supporting scientific studies are implemented. The medical research network is already in use by 345 active users from 240 institutions in 18 countries. More than 960 000 item entries and 7962 images from 1260 patients are stored. Challenges, which resulted from the fact that only 16 % of the centres had more than 2 patients per year, have been addressed by an intuitive user interface, hierarchical roles, user required features, and experienced support. The system has already been used extensively and has helped to make significant progress in the area of Neuroblastoma research.

Entities:  

Mesh:

Year:  2009        PMID: 19273232     DOI: 10.2741/3410

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  2 in total

1.  Paradigm shift or annoying distraction: emerging implications of web 2.0 for clinical practice.

Authors:  H Spallek; J O'Donnell; M Clayton; P Anderson; A Krueger
Journal:  Appl Clin Inform       Date:  2010-04-21       Impact factor: 2.342

Review 2.  Electronic case report forms and electronic data capture within clinical trials and pharmacoepidemiology.

Authors:  David A Rorie; Robert W V Flynn; Kerr Grieve; Alexander Doney; Isla Mackenzie; Thomas M MacDonald; Amy Rogers
Journal:  Br J Clin Pharmacol       Date:  2017-04-22       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.